Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
US Army
Accenture
Deloitte
Chinese Patent Office
Merck

Generated: July 16, 2019

DrugPatentWatch Database Preview

Patent: 9,556,182

Try a free trialSee Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,556,182
Title:Inhibitors of Bruton\'s tyrosine kinase
Abstract: Described herein are irreversible kinase inhibitor compounds, methods for synthesizing such irreversible inhibitors, and methods for using such irreversible inhibitors in the treatment of diseases. Further described herein are methods, assays and systems for determining an appropriate irreversible inhibitor of a protein, including a kinase.
Inventor(s): Honigberg; Lee (San Francisco, CA), Verner; Erik (Belmont, CA), Buggy; Joseph J. (Mountain View, CA), Loury; David (Incline Village, NV), Chen; Wei (Fremont, CA)
Assignee: Pharmacylics LLC (Sunnyvale, CA)
Application Number:14/794,685
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 9,556,182
Patent Claims:see list of patent claims

Details for Patent 9,556,182

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Genentech HERCEPTIN trastuzumab VIAL; INTRAVENOUS 103792 001 1998-09-25 ➤ Try a Free Trial Pharmacylics LLC (Sunnyvale, CA) ➤ Try a Free Trial RX Orphan search
Genentech RITUXAN rituximab VIAL 103705 001 1997-11-26 ➤ Try a Free Trial Pharmacylics LLC (Sunnyvale, CA) ➤ Try a Free Trial RX search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

International Patent Family for US Patent 9,556,182

Country Patent Number Publication Date
South Africa 200901784 Jan 26, 2011
South Africa 201007561 Sep 26, 2012
South Africa 201100893 Mar 27, 2013
South Africa 201207075 Jun 26, 2013
World Intellectual Property Organization (WIPO) 2008039218 Apr 03, 2008
World Intellectual Property Organization (WIPO) 2008039218 May 29, 2008
World Intellectual Property Organization (WIPO) 2008121742 Nov 27, 2008
Country Patent Number Publication Date

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Healthtrust
Citi
UBS
Fish and Richardson
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.